Projekt

Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland – BERINGMELANOMA

Laufend - Rekrutierung – laufend · 2021 bis 2027

Wagner Nikolaus